DK484585A - Micellulaere partikelkompositioner, hvori er indkapslet billedtagende og kemoterapeutiske midler for tumorer, og kompositionernes anvendelse - Google Patents

Micellulaere partikelkompositioner, hvori er indkapslet billedtagende og kemoterapeutiske midler for tumorer, og kompositionernes anvendelse Download PDF

Info

Publication number
DK484585A
DK484585A DK484585A DK484585A DK484585A DK 484585 A DK484585 A DK 484585A DK 484585 A DK484585 A DK 484585A DK 484585 A DK484585 A DK 484585A DK 484585 A DK484585 A DK 484585A
Authority
DK
Denmark
Prior art keywords
micellular
tumors
compositions
chemotherapeutic agents
encouraged
Prior art date
Application number
DK484585A
Other languages
English (en)
Other versions
DK167556B1 (da
DK484585D0 (da
Inventor
Cary Arnett Presant
Richard Thomas Proffitt
Raymond Leo Teplitz
Lawrence Ernest Williams
George Wing-Yiu Tin
Original Assignee
Hope Nat Medical Center
Vestar Research Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/663,550 external-priority patent/US5441745A/en
Priority claimed from US06/663,503 external-priority patent/US5435989A/en
Application filed by Hope Nat Medical Center, Vestar Research Inc filed Critical Hope Nat Medical Center
Publication of DK484585D0 publication Critical patent/DK484585D0/da
Publication of DK484585A publication Critical patent/DK484585A/da
Application granted granted Critical
Publication of DK167556B1 publication Critical patent/DK167556B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1217—Dispersions, suspensions, colloids, emulsions, e.g. perfluorinated emulsion, sols
    • A61K51/1234—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dispersion Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK484585A 1984-10-22 1985-10-22 Anvendelse af en micellepartikelkomposition, hvori partiklerne i sig selv har indkapslet et kemoterapeutisk middel, til fremstilling af et intravenoest indgiveligt farmaceutisk praeparat til indfoerelse af partikelkompositionen og det kemoterapeutiske middel i tumorceller DK167556B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US66350384 1984-10-22
US66355084 1984-10-22
US06/663,550 US5441745A (en) 1982-03-30 1984-10-22 Method of delivering micellular particles encapsulating chemotherapeutic agents to tumors in a body
US06/663,503 US5435989A (en) 1982-03-30 1984-10-22 Method of targeting a specific location in a body

Publications (3)

Publication Number Publication Date
DK484585D0 DK484585D0 (da) 1985-10-22
DK484585A true DK484585A (da) 1986-04-23
DK167556B1 DK167556B1 (da) 1993-11-22

Family

ID=27098764

Family Applications (2)

Application Number Title Priority Date Filing Date
DK482685A DK482685D0 (da) 1984-10-22 1985-10-21 Fremgangsmaade til tilfoersel af micellulaere partikler, der indkapslerbilleddannende og kemoterapeutiske midler, til tumorer i et legeme
DK484585A DK167556B1 (da) 1984-10-22 1985-10-22 Anvendelse af en micellepartikelkomposition, hvori partiklerne i sig selv har indkapslet et kemoterapeutisk middel, til fremstilling af et intravenoest indgiveligt farmaceutisk praeparat til indfoerelse af partikelkompositionen og det kemoterapeutiske middel i tumorceller

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK482685A DK482685D0 (da) 1984-10-22 1985-10-21 Fremgangsmaade til tilfoersel af micellulaere partikler, der indkapslerbilleddannende og kemoterapeutiske midler, til tumorer i et legeme

Country Status (11)

Country Link
EP (1) EP0179444B1 (da)
JP (1) JPH0747533B2 (da)
KR (1) KR900004802B1 (da)
AT (1) ATE64298T1 (da)
CA (1) CA1298548C (da)
DE (2) DE3583204D1 (da)
DK (2) DK482685D0 (da)
HK (1) HK119993A (da)
IE (1) IE58659B1 (da)
LU (1) LU88811I2 (da)
NL (1) NL960020I1 (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE60901B1 (en) * 1986-08-21 1994-08-24 Vestar Inc Improved treatment of systemic fungal infections with phospholipid particles encapsulating polyene antifungal antibiotics
US5043107A (en) * 1986-08-21 1991-08-27 Vestar Research, Inc. Preparation small unilamellar vesicles including polyene antifungal antibiotics
IL88076A (en) * 1987-10-28 1993-01-14 Nippon Shinyaku Co Ltd Fat emulsions as drug carriers
AU598958B2 (en) 1987-11-12 1990-07-05 Vestar, Inc. Improved amphotericin b liposome preparation
US5648532A (en) * 1993-06-03 1997-07-15 The Regents Of The University Of California Compositions for boron neutron capture therapy and methods thereof
JPH10513466A (ja) * 1995-02-09 1998-12-22 シェリング アクチェンゲゼルシャフト 脈管内空間を視覚化するための造影剤を含むリポソーム
NO312708B1 (no) * 2000-02-21 2002-06-24 Anticancer Therapeutic Inv Sa Radioaktive liposomer til terapi
JP2007512221A (ja) * 2003-11-21 2007-05-17 富士フイルム株式会社 疎水性キレート化合物を含有するリポソームを含む造影剤
EP1745788A1 (de) * 2005-07-22 2007-01-24 KTB Tumorforschungsgesellschaft mbH Acylglycerophospholipide zur Behandlung von Krebs und Tumorkachexie
WO2012066896A1 (ja) * 2010-11-19 2012-05-24 Kato Junji 組合わせ医薬製剤

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4310505A (en) * 1979-11-08 1982-01-12 California Institute Of Technology Lipid vesicles bearing carbohydrate surfaces as lymphatic directed vehicles for therapeutic and diagnostic substances
JPS59122423A (ja) * 1982-12-28 1984-07-14 Green Cross Corp:The 制癌剤含有脂肪乳剤
JPS59163315A (ja) * 1983-03-09 1984-09-14 Mitsui Pharmaceut Inc カルモフ−ル含有リポソ−ム

Also Published As

Publication number Publication date
IE58659B1 (en) 1993-11-03
DK167556B1 (da) 1993-11-22
DE3583204D1 (de) 1991-07-18
CA1298548C (en) 1992-04-07
EP0179444A2 (en) 1986-04-30
KR900004802B1 (ko) 1990-07-06
JPH0747533B2 (ja) 1995-05-24
IE852602L (en) 1986-04-22
DK482685D0 (da) 1985-10-21
EP0179444B1 (en) 1991-06-12
KR860003514A (ko) 1986-05-26
DK484585D0 (da) 1985-10-22
ATE64298T1 (de) 1991-06-15
EP0179444A3 (en) 1987-08-12
NL960020I1 (nl) 1996-11-01
JPS61158932A (ja) 1986-07-18
LU88811I2 (fr) 1996-11-05
DE19675031I2 (de) 2008-04-10
HK119993A (en) 1993-11-12

Similar Documents

Publication Publication Date Title
AU4515985A (en) New tetrapyrrole therapeutic agents
MY110186A (en) The use of tyloxapol as a nanoparticle stabilizer and dispersant.
ES8304797A1 (es) "procedimiento para la preparacion de nuevas formas orales de dipiridamol, en forma de granulados, pastillas o tabletas".
EP0430968A4 (en) Compounds, compositions and method for binding bio-affecting substances to surface membranes of bio-particles
ATE121082T1 (de) Tri-azamakrozyklen und deren metall komplexe.
AU5418486A (en) Anthracycline antineoplastic agents encapsulated in phospholipid micellular particles and methods for using same for tumor therapy
GB2128088B (en) Oral mopidamol preparations
HU9200226D0 (en) Active agent particles with modified cover
DK484585D0 (da) Micellulaere partikelkompositioner, hvori er indkapslet billedtagende og kemoterapeutiske midler for tumorer, og kompositionernes anvendelse
EP0637246A4 (en) METHODS OF TREATING CANCER WITH C-REACTIVE PROTEIN.
GR80951B (en) Pharmaceutical compositions and method for preparing phosphatidylserine compositions useful in treating central nervous system disorders without effects on blood coagulation
ZA954099B (en) Combination of necrosis-inducing substances with substances which are activated by necroses for the selective therapy of tumors and inflammatory disorders
MX9504023A (es) Composicion farmaceutica y transdermicamente activa que contiene acido 5-aminolaevulinico y procedimiento para su preparacion.
GR3032041T3 (en) Idebenone compositions for treating Alzheimer's disease.
KR930700163A (ko) 연조직 종양의 치료 및/또는 진단 방법
GR850416B (da)
EP0135189A3 (en) Pharmaceutically useful malonamides
ATE70456T1 (de) Verwendung von micellaren partikeln zur herstellung von zusammensetzungen zum beschiessen von tumoren in menschen und deren verwendung.
EP0201005A3 (en) 99mtc(iii)myocardial imaging agents which are non-reducable in vivo
Anghileri et al. 57Co-hematoporphyrin accumulation by experimental tumors
FR2667070B1 (da)
Wheeler et al. Are inducible components involved in the repair of irradiated neuronal and brain tumour DNA?
IT1242026B (it) Composizione farmaceutica contenente un complesso ferro-schizokinene per il trattamento dell'anemia ferropenica.
Djajapranata et al. Gastrozepin in gastritis.
JPS5690015A (en) Preventive and remedy containing human ceruloplasmin as main component

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
CTFF Application for supplementary protection certificate (spc) filed

Free format text: CA 1996 00017, 960906

PUP Patent expired
CTFF Application for supplementary protection certificate (spc) filed

Spc suppl protection certif: CA 1996 00017

Filing date: 19960906

Expiry date: 20100524